1 Introduction to Research & Analysis Reports
    1.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Overall Market Size
    2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size: 2021 VS 2027
    2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in Global Market
    3.2 Top Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies Ranked by Revenue
    3.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Companies
    3.4 Top 3 and Top 5 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in Global Market
        3.6.1 List of Global Tier 1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Markets, 2021 & 2027
        4.1.2 PCR
        4.1.3 In-situ Hybridization
        4.1.4 Immunohistochemistry
        4.1.5 Sequencing
        4.1.6 Others
    4.2 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue & Forecasts
        4.2.1 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2021
        4.2.2 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2022-2027
        4.2.3 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2021 & 2027
        5.1.2 Oncology
        5.1.3 Neurological Disorders
        5.1.4 Cardiovascular Disease
        5.1.5 Immunological Disorders
        5.1.6 Others
    5.2 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue & Forecasts
        5.2.1 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2021
        5.2.2 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2022-2027
        5.2.3 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2021 & 2027
    6.2 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue & Forecasts
        6.2.1 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2021
        6.2.2 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2022-2027
        6.2.3 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
        6.3.2 US Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.3.3 Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.3.4 Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
        6.4.2 Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.4.3 France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.4.4 U.K. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.4.5 Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.4.6 Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.4.7 Nordic Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.4.8 Benelux Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
        6.5.2 China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.5.3 Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.5.4 South Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.5.5 Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.5.6 India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
        6.6.2 Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.6.3 Argentina Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
        6.7.2 Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.7.3 Israel Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.7.4 Saudi Arabia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
        6.7.5 UAE Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
7 Players Profiles
    7.1 Qiagen NV
        7.1.1 Qiagen NV Corporate Summary
        7.1.2 Qiagen NV Business Overview
        7.1.3 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.1.4 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.1.5 Qiagen NV Key News
    7.2 GE Healthcare
        7.2.1 GE Healthcare Corporate Summary
        7.2.2 GE Healthcare Business Overview
        7.2.3 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.2.4 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.2.5 GE Healthcare Key News
    7.3 Agilent Technologies
        7.3.1 Agilent Technologies Corporate Summary
        7.3.2 Agilent Technologies Business Overview
        7.3.3 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.3.4 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.3.5 Agilent Technologies Key News
    7.4 F Hoffman La Roche
        7.4.1 F Hoffman La Roche Corporate Summary
        7.4.2 F Hoffman La Roche Business Overview
        7.4.3 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.4.4 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.4.5 F Hoffman La Roche Key News
    7.5 Foundation Medicine
        7.5.1 Foundation Medicine Corporate Summary
        7.5.2 Foundation Medicine Business Overview
        7.5.3 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.5.4 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.5.5 Foundation Medicine Key News
    7.6 Thermo Fisher Scientific Inc.
        7.6.1 Thermo Fisher Scientific Inc. Corporate Summary
        7.6.2 Thermo Fisher Scientific Inc. Business Overview
        7.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.6.4 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.6.5 Thermo Fisher Scientific Inc. Key News
    7.7 Leica Biosystems Nussloch GmBH
        7.7.1 Leica Biosystems Nussloch GmBH Corporate Summary
        7.7.2 Leica Biosystems Nussloch GmBH Business Overview
        7.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.4.4 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.7.5 Leica Biosystems Nussloch GmBH Key News
    7.8 Pfizer
        7.8.1 Pfizer Corporate Summary
        7.8.2 Pfizer Business Overview
        7.8.3 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
        7.8.4 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
        7.8.5 Pfizer Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer